Get your full text copy in PDF

Cutaneous changes as a symptom of either HCV infection or therapy complication

Anna Wozniacka, Maciej S. Jablkowski

Med Sci Tech 2010; 51(2):

ID: 881274

The hepatitis type C virus (HCV) and chronic hepatic disease, which the virus induces, are significant health problems of truly global magnitude. According to WHO data, approximately 180 million people are infected with HCV world-wide. The majority of patients, with either acute or chronic infection, do not demonstrate evident clinical symptoms of liver disease, while concomitant, non-specific extrahepatic symptoms are fairly often observed, affecting joints, muscles, nervous system, gastric tract or skin. An accurate, consolidated evaluation of observed extrahepatic symptoms could become a valuable diagnostic indication, decisive for the accurate diagnosis of HCV infection.
This paper presents the pathogenesis, epidemiology and the clinical picture of HCV infection, with particular consideration of cutaneous changes, which may either accompany HCV or be an adverse effect of combined therapy with interferon alpha and ribavirin.

Keywords: cutaneous changes, viral hepatitis, HCV, cutaneous changes, viral hepatitis, HCV, interferon alfa, cutaneous changes, viral hepatitis, HCV, interferon alfa

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

I agree